207 related articles for article (PubMed ID: 27242346)
21. [Effect of S1PR2 inhibition on epithelial ovarian cancer SKOV3 cell proliferation in vitro and in vivo].
Dai L; Liu YX; Xie L; Di W
Zhonghua Fu Chan Ke Za Zhi; 2018 Feb; 53(2):106-110. PubMed ID: 29534379
[No Abstract] [Full Text] [Related]
22. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
[TBL] [Abstract][Full Text] [Related]
23. Comparison of two kinds of orthotopic xenograft models for human ovarian cancer.
Zhu G; Hong L; Wang S; Junhong Cai ; Yang Z; Yao M
Eur J Gynaecol Oncol; 2014; 35(6):724-7. PubMed ID: 25556281
[TBL] [Abstract][Full Text] [Related]
24. Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCAD.
Chekerov R; Braicu I; Castillo-Tong DC; Richter R; Cadron I; Mahner S; Woelber L; Marth C; Van Gorp T; Speiser P; Zeillinger R; Vergote I; Sehouli J
Int J Gynecol Cancer; 2013 Feb; 23(2):268-75. PubMed ID: 23358178
[TBL] [Abstract][Full Text] [Related]
25. Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic.
Wahner Hendrickson AE; Hawthorne KM; Goode EL; Kalli KR; Goergen KM; Bakkum-Gamez JN; Cliby WA; Keeney GL; Visscher DW; Tarabishy Y; Oberg AL; Hartmann LC; Maurer MJ
Gynecol Oncol; 2015 Apr; 137(1):77-85. PubMed ID: 25620544
[TBL] [Abstract][Full Text] [Related]
26. Toward operative in vivo fluorescence imaging of the c-Met proto-oncogene for personalization of therapy in ovarian cancer.
Liu S; Zheng Y; Volpi D; El-Kasti M; Klotz D; Tullis I; Henricks A; Campo L; Myers K; Laios A; Thomas P; Ng T; Dhar S; Becker C; Vojnovic B; Ahmed AA
Cancer; 2015 Jan; 121(2):202-13. PubMed ID: 25209149
[TBL] [Abstract][Full Text] [Related]
27. Ovarian carcinoma: quantitative biexponential MR imaging relaxometry reveals the dynamic recruitment of ferritin-expressing fibroblasts to the angiogenic rim of tumors.
Vandsburger MH; Radoul M; Addadi Y; Mpofu S; Cohen B; Eilam R; Neeman M
Radiology; 2013 Sep; 268(3):790-801. PubMed ID: 23801774
[TBL] [Abstract][Full Text] [Related]
28. Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancer.
Cocco E; Shapiro EM; Gasparrini S; Lopez S; Schwab CL; Bellone S; Bortolomai I; Sumi NJ; Bonazzoli E; Nicoletti R; Deng Y; Saltzman WM; Zeiss CJ; Centritto F; Black JD; Silasi DA; Ratner E; Azodi M; Rutherford TJ; Schwartz PE; Pecorelli S; Santin AD
Int J Cancer; 2015 Dec; 137(11):2618-29. PubMed ID: 26060989
[TBL] [Abstract][Full Text] [Related]
29. [Expression of Jagged1 mRNA in human epithelial ovarian carcinoma tissues and effect of RNA interference of Jagged1 on growth of xenograft in nude mice].
Liu GY; Gao ZH; Li L; Song TT; Sheng XG
Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):448-53. PubMed ID: 27356481
[TBL] [Abstract][Full Text] [Related]
30. Loss of ITM2A, a novel tumor suppressor of ovarian cancer through G2/M cell cycle arrest, is a poor prognostic factor of epithelial ovarian cancer.
Nguyen TM; Shin IW; Lee TJ; Park J; Kim JH; Park MS; Lee EJ
Gynecol Oncol; 2016 Mar; 140(3):545-53. PubMed ID: 26691219
[TBL] [Abstract][Full Text] [Related]
31. Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer.
Wang X; Zhu Q; Lin Y; Wu L; Wu X; Wang K; He Q; Xu C; Wan X; Wang X
Br J Cancer; 2017 Oct; 117(9):1371-1382. PubMed ID: 28898232
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
Cancer Lett; 2015 Jun; 362(1):122-30. PubMed ID: 25819031
[TBL] [Abstract][Full Text] [Related]
33. ABT-898 induces tumor regression and prolongs survival in a mouse model of epithelial ovarian cancer.
Campbell N; Greenaway J; Henkin J; Petrik J
Mol Cancer Ther; 2011 Oct; 10(10):1876-85. PubMed ID: 21844212
[TBL] [Abstract][Full Text] [Related]
34. The role of minimally invasive interval debulking surgery in advanced epithelial ovarian cancer.
Menderes G; Black JD; Azodi M
Expert Rev Anticancer Ther; 2016 Sep; 16(9):899-901. PubMed ID: 27477495
[No Abstract] [Full Text] [Related]
35. Advances in the management of epithelial ovarian cancer.
Berkenblit A; Cannistra SA
J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
[TBL] [Abstract][Full Text] [Related]
36. Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations.
Ricci F; Bizzaro F; Cesca M; Guffanti F; Ganzinelli M; Decio A; Ghilardi C; Perego P; Fruscio R; Buda A; Milani R; Ostano P; Chiorino G; Bani MR; Damia G; Giavazzi R
Cancer Res; 2014 Dec; 74(23):6980-90. PubMed ID: 25304260
[TBL] [Abstract][Full Text] [Related]
37. Appropriate Recommendations for Surgical Debulking in Stage IV Ovarian Cancer.
Chern JY; Curtin JP
Curr Treat Options Oncol; 2016 Jan; 17(1):1. PubMed ID: 26714493
[TBL] [Abstract][Full Text] [Related]
38. Human umbilical blood mononuclear cell-derived mesenchymal stem cells serve as interleukin-21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice.
Hu W; Wang J; He X; Zhang H; Yu F; Jiang L; Chen D; Chen J; Dou J
Biotechnol Appl Biochem; 2011; 58(6):397-404. PubMed ID: 22172102
[TBL] [Abstract][Full Text] [Related]
39. Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer.
Fruscio R; Sina F; Dolci C; Signorelli M; Crivellaro C; Dell'Anna T; Cuzzocrea M; Guerra L; Milani R; Messa C
Gynecol Oncol; 2013 Dec; 131(3):689-93. PubMed ID: 24076062
[TBL] [Abstract][Full Text] [Related]
40. Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy?
Hynninen J; Lavonius M; Oksa S; Grénman S; Carpén O; Auranen A
Gynecol Oncol; 2013 Feb; 128(2):229-32. PubMed ID: 23142076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
